Concepedia

Author

A. H. van Gennip

University of Amsterdam

Also Known As

A H VAN GENNIP, A H Van Gennip, A H van Gennip, A. H. Van Gennip, A. H. van Gennip, A.H van Gennip, A.H. VAN GENNIP, A.H. Van Gennip, A.H. van Gennip, Albert H Van Gennip

100

Publications

3.8K

Citations

27

H-Index

92

Concepts

All Affiliations

University of AmsterdamAmsterdam UMC Location University of AmsterdamEmma KinderziekenhuisRadboud University NijmegenWilhelmina Children's Hospital
AH

About

A. H. van Gennip is an author at University of Amsterdam specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

20

33

1.7K

2

Natural Sciences

3

3

116

3

Health Sciences

2

2

142

4

Public Health

1

1

33

5

Allergy

1

1

16

A. H. van Gennip

×

52

Publications

3.2K

Citations

25

H-Index

YearCitations

X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localization, and evidence for disturbed monoamine metabolism.

Han G. Brunner, Marcel Nelen, Peter van Zandvoort,

PubMed

1993

369

Clinical implications of dihydropyrimidine dehydrogenase (DPD) deficiency in patients with severe 5-fluorouracil-associated toxicity: identification of new mutations in the DPD gene.

André B. P. Kuilenburg, Janet Haasjes, Dick J. Richel,

Data Archiving and Networked Services (DANS)

2000

360

Prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5'-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)- related toxicity compared with controls.

Martin Kristian Raida, Wolfgang Schwabe, Peter Häusler,

PubMed

2001

232

L‐2‐Hydroxyglutaric aciduria: an inborn error of metabolism?

M. Durán, J.P. Kamerling, H. D. Bakker,

Journal of Inherited Metabolic Disease

1980

220

Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes.

Jacques W.M. Lenders, Graeme Eisenhofer, N.G.G.M. Abeling,

Journal of Clinical Investigation

1996

152

Quantitative plasma acylcarnitine analysis using electrospray tandem mass spectrometry for the diagnosis of organic acidaemias and fatty acid oxidation defects

P. Vreken, A. E. M. van Lint, Albert H. Bootsma,

Journal of Inherited Metabolic Disease

1999

144

Human Polymorphism in Drug Metabolism: Mutation in the Dihydropyrimidine Dehydrogenase Gene Results in Exon Skipping and Thymine Uracilurea

Rutger Meinsma, Pedro M. Fernández‐Salguero, André B. P. Kuilenburg,

DNA and Cell Biology

1995

133

Long‐chain 3‐hydroxyacyl‐CoA dehydrogenase deficiency: Identification of a new inborn error of mitochondrial fatty acid<i>β</i>‐oxidation

R. J. A. Wanders, Lodewijk IJlst, A. H. van Gennip,

Journal of Inherited Metabolic Disease

1990

121

X‐linked cardioskeletal myopathy and neutropenia (Barth syndrome): Respiratory‐chain abnormalities in cultured fibroblasts

P. G. Barth, Coby Van den Bogert, Pieter A. Bolhuis,

Journal of Inherited Metabolic Disease

1996

99

Rapid stable isotope dilution analysis of very-long-chain fatty acids, pristanic acid and phytanic acid using gas chromatography–electron impact mass spectrometry

P. Vreken, A.E.M van Lint, Albert H. Bootsma,

Journal of Chromatography B Biomedical Sciences and Applications

1998

99

Page 1